Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

World Congress of Bronchology and Interventional Pulmonology 2026

We are excited to announce that the World Congress of Bronchology and Interventional Pulmonology 2026 will be hosted by the Thoracic Society of Australia and New Zealand in the vibrant city of Melbourne, Australia. We are excited to announce that...

3rd Global Summit on Heart and Cardiovascular Care 2026

3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress 2026), taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the...

VietPharma&Tech 2026

2026 / The International Exhibition on Analytical and Laboratory Equipment in Vietnam - VietLab Expo 2024 from November 21 - 23, 2026 at Saigon Exhibition & Convention Center (SECC). Vietnam Medical Devices Association highly appreciates Vietnam...

6th International Conference on Cardiology 2026

Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious event will take place on November 13–14, 2026. 6th International Conference on Cardiology. Held in the vibrant city of Bangkok, Thailand, this prestigious...

Global Pharma Supply Chain & Logistics Forum 2026

The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma and healthcare supply chain leaders. The Global Pharma Supply Chain & Logistics Forum 2026 is a premier invite-only event uniting top pharma...

NextGen Pharma 2026

NextGen Pharma, a premier global forum dedicated to exploring the latest innovations, emerging technologies, and future-focused strategies in the pharmaceutical industry. NextGen Pharma, a premier global forum dedicated to exploring the latest...

2nd International Conference on Drug Discovery 2026

groundbreaking innovations in drug research, pharmaceutical sciences, and biotechnology. Scheduled to take place on October 12–13, 2026, in Singapore, the conference serves as a global platform to exchange knowledge, discuss emerging trends, and...

Risk & Compliance Pharma & Life Sciences Conference 2026

The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One America Square in London, UK. The 4th Annual Risk & Compliance Pharma & Life Sciences Conference takes place on October 1, 2026, at One...

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

served as Chief Executive Officer of a Catalio Capital-backed oncology company, which he led from formation through a $14 million seed financing to a successful corporate transaction. He previously held Chief Operating Officer and Chief Technology...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with gene-to-antibody delivery in as little as 7 calendar days, plus 5 days for shipping, for...

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

multiple antibody formats, including scFv, VHH, Fab, and full-length IgG. Its high-throughput workflow can process up to 1,500 candidates per day, with gene-to-antibody delivery in as little as 7 calendar days, plus 5 days for shipping, for...

LEVEL Relief Protab Reduced Everyday Aches and Pain in an Independent 29-Day Study

their pain immediately before each dose and again in the hours after, participants' scores fell from 5.26 to 3.56 on a 0–10 scale — a 32% drop (p...

FDA Updates WINREVAIR™ Label with HYPERION Phase 3 Trial Data in Adults Newly Diagnosed with PAH

signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the risk of clinical worsening...

Padagis Expands Workplace Naloxone Access by Providing Free Nasal Sprays to Qualifying Businesses

the American National Standards Institute (ANSI) and the International Safety Equipment Association (ISEA), ANSI/ISEA Z308.1-2026. This new standard reflects a significant shift in how employers approach emergency preparedness, recognizing naloxone...

StimCardio’s NeuroPulse Study Reports a Substantial Reduction in Recurrent Atrial Fibrillation Events Following Ablation Using Non-Invasive Wearable Neuromodulation

and lead investigator of the study. Key Findings Statistically Significant reduction in recurrent atrial arrhythmia events: 12 events with MNS compared with 28 with sham in the post-blanking sensitivity analysis (p = 0.025) 90.0% freedom from...

Bruker Receives Order for High-Field NMR Systems to Support a Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley.

Bruker Corporation announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center. The investment will enhance access to...

Scitara Appoints Mike Tarselli as Chief Strategy Officer to Drive Growth in Lab Intelligence

Scitara, the Lab Connectivity and AI platform company serving the life sciences and biopharma industries, announced a new strategic direction for the company alongside the appointment of Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer. The...

Stasis Introduces the First Day-and-Night Supplement System Built for Children Who Take Stimulants

stimulants, today introduced Stasis Kids, a day-and-night nutritional supplement system made for children ages 6 to 17. In 2023, 16.5 million people in the United States were dispensed a prescription stimulant, up 48 percent in a decade, according...

Chemify Becomes the First Chemistry Hyperscaler with £22 Million in Grants from Scottish Enterprise and the UK Government

chemistry to partners across pharmaceuticals, speciality chemicals and advanced materials. The grant package includes £16 million ($21.6 million) from Scottish Enterprise and £6 million ($8.1 million) from the UK Government. Chemify’s previously...

Lundbeck Receives Marketing Authorization for Vyepti® (eptinezumab) in Japan for the Prevention of Migraine Attacks

often accompanied by nausea, vomiting, and sensitivity to light and sound. In Japan, migraine affects an estimated 8.4%–11.0% of the population1 and is the fourth leading cause of years lived with disability.2 Beyond the physical symptoms, migraine...